Infiltration of γδ T cells, IL-17+ T cells and FoxP3+ T cells in human breast cancer

被引:27
作者
Allaoui, Roni [1 ]
Hagerling, Catharina [1 ]
Desmond, Eva [1 ]
Warfvinge, Carl-Fredrik [2 ]
Jirstrom, Karin [2 ]
Leandersson, Karin [1 ]
机构
[1] Lund Univ, Dept Translat Med, Canc Immunol, Malmo, Sweden
[2] Lund Univ, Dept Clin Sci Lund, Oncol & Pathol, Lund, Sweden
关键词
Breast cancer; T lymphocytes; TILs; prognosis; unconventional T cells; IMMUNE CELLS; TH17; CELLS; LYMPHOCYTES; CHEMOTHERAPY; EXPRESSION; PREDICT; PROMOTE; TUMORS; MOUSE;
D O I
10.3233/CBM-170026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Tumor-infiltrating lymphocytes (TILs) have a strong prognostic value in various forms of cancers. These data often refer to use of the pan-T cell marker CD3, or the cytotoxic T lymphocyte marker CD8 alpha. However, T cells are a heterogeneous group of cells with a wide array of effector mechanisms ranging from immunosuppression to cytotoxicity. OBJECTIVE: In this study we have investigated the prognostic effects of some unconventional T cell subtypes in breast cancer; gamma delta T cells, IL-17(+) T cells and FoxP3(+) T cells (T-regs) in relation to the conventional CD3 and CD8 alpha T cell markers. METHODS: This was done using immunohistochemistry on a human breast cancer tissue microarray consisting of 498 consecutive cases of primary breast cancer. RESULTS: Infiltration of gamma delta T cells and T cell infiltration in general (CD3), correlated with a good prognosis, while T-reg infiltration with a worse. Infiltration of gamma delta T cells was associated with a significantly improved clinical outcome in all breast cancer subtypes except triple negative tumors. Only infiltration of either CD3(+) or CD8 alpha(+) cells was independently associated with better prognosis for all breast cancer patients. CONCLUSIONS: This study sheds further light on the prognostic impact of various T cell subtypes in breast cancer.
引用
收藏
页码:395 / 409
页数:15
相关论文
共 42 条
[1]   Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 [J].
Adams, Sylvia ;
Gray, Robert J. ;
Demaria, Sandra ;
Goldstein, Lori ;
Perez, Edith A. ;
Shulman, Lawrence N. ;
Martino, Silvana ;
Wang, Molin ;
Jones, Vicky E. ;
Saphner, Thomas J. ;
Wolff, Antonio C. ;
Wood, William C. ;
Davidson, Nancy E. ;
Sledge, George W. ;
Sparano, Joseph A. ;
Badve, Sunil S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2959-+
[2]   Ligation of CD8α on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity [J].
Addison, EG ;
North, J ;
Bakhsh, I ;
Marden, C ;
Haq, S ;
Al-Sarraj, S ;
Malayeri, R ;
Wickremasinghe, RG ;
Davies, JK ;
Lowdell, MW .
IMMUNOLOGY, 2005, 116 (03) :354-361
[3]   The Multifaceted Role of Th17 Lymphocytes and Their Associated Cytokines in Cancer [J].
Alizadeh, Darya ;
Katsanis, Emmanuel ;
Larmonier, Nicolas .
CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013, :957878
[4]   Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy [J].
Apetoh, Lionel ;
Ghiringhelli, Francois ;
Tesniere, Antoine ;
Obeid, Michel ;
Ortiz, Carla ;
Criollo, Alfredo ;
Mignot, Gregoire ;
Maiuri, M. Chiara ;
Ullrich, Evelyn ;
Saulnier, Patrick ;
Yang, Huan ;
Amigorena, Sebastian ;
Ryffel, Bernard ;
Barrat, Franck J. ;
Saftig, Paul ;
Levi, Francis ;
Lidereau, Rosette ;
Nogues, Catherine ;
Mira, Jean-Paul ;
Chompret, Agnes ;
Joulin, Virginie ;
Clavel-Chapelon, Francoise ;
Bourhis, Jean ;
Andre, Fabrice ;
Delaloge, Suzette ;
Tursz, Thomas ;
Kroemer, Guido ;
Zitvogel, Laurence .
NATURE MEDICINE, 2007, 13 (09) :1050-1059
[5]   Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer [J].
Bense, Rico D. ;
Sotiriou, Christos ;
Piccart-Gebhart, Martine J. ;
Haanen, John B. A. G. ;
van Vugt, Marcel A. T. M. ;
de Vries, Elisabeth G. E. ;
Schroeder, Carolien P. ;
Fehrmann, Rudolf S. N. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (01)
[6]   Oestrogen receptors α and β show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer [J].
Borgquist, S. ;
Holm, C. ;
Stendahl, M. ;
Anagnostaki, L. ;
Landberg, G. ;
Jirstrom, K. .
JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (02) :197-202
[7]   γδ T cells:: Functional plasticity and heterogeneity [J].
Carding, SR ;
Egan, PJ .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (05) :336-345
[8]   Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor [J].
Chen, Wen-Chung ;
Lai, Yu-Hsuan ;
Chen, Hung-Yu ;
Guo, How-Ran ;
Su, Ih-Jen ;
Chen, Helen H. W. .
HISTOPATHOLOGY, 2013, 63 (02) :225-233
[9]   Human and mouse CD8+CD25+FOXP3+ regulatory T cells at steady state and during interleukin-2 therapy [J].
Churlaud, Guillaume ;
Pitoiset, Fabien ;
Jebbawi, Fadi ;
Lorenzon, Roberta ;
Bellier, Bertrand ;
Rosenzwajg, Michelle ;
Klatzmann, David .
FRONTIERS IN IMMUNOLOGY, 2015, 6
[10]   IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis [J].
Coffelt, Seth B. ;
Kersten, Kelly ;
Doornebal, Chris W. ;
Weiden, Jorieke ;
Vrijland, Kim ;
Hau, Cheei-Sing ;
Verstegen, Niels J. M. ;
Ciampricotti, Metamia ;
Hawinkels, Lukas J. A. C. ;
Jonkers, Jos ;
de Visser, Karin E. .
NATURE, 2015, 522 (7556) :345-+